Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

A new compound was effective for imaging prostate cancer in rats.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Hair loss gene linked to prostate issues.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Finasteride treats hair loss but may affect prostate cancer detection.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The nutritional supplement improved hair quality and reduced hair loss.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Cosmetics can contain harmful chemicals that may cause health issues.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Structured prevention strategies and Brain Health Clinics can help prevent Alzheimer's.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.